Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2019

Open Access 01-12-2019 | Spirometry | Research article

Prevalence of chronic obstructive pulmonary disease (COPD) and its associated factors among adults in Abeshge District, Ethiopia: a cross sectional study

Authors: Gashaw Garedew Woldeamanuel, Alemu Basazin Mingude, Teshome Gensa Geta

Published in: BMC Pulmonary Medicine | Issue 1/2019

Login to get access

Abstract

Background

Chronic obstructive pulmonary disease (COPD) is one of the major public health problems worldwide. Despite an increasing burden of COPD in the world, it is often a neglected disease in low income countries and COPD prevalence studies are rare in Sub-Saharan Africa. The objective of this study was to determine the prevalence of COPD and its associated factors among adults in Ethiopia.

Methods

A community based cross sectional study was conducted from February 5 to May 20, 2019 in Abeshge district, Southern Ethiopia. A total of 734 adults aged at least 30 years were selected using multistage cluster sampling technique and included in the study. All participants were interviewed about socio-demographic characteristics, respiratory symptoms, smoking status and clinical characteristics. Moreover, all participants underwent spirometry. We defined COPD as a post-bronchodilator FEV1/FVC of less than 70%. Data were entered into Epi-data manager 4.4 and analyzed using SPSS version 23. Descriptive statistics and binary logistic regression analysis were used and p-value < 0.05 was considered as significant.

Results

Of the 779 adults invited to participate, 734 adults (421 men and 313 women) were participated in this study. The mean (SD) age of the participants was 39.15 (± 9.36) years, within the age range of 30–75 years. The prevalence of COPD was 17.8% (95% confidence interval [CI], 15.1–20.6). Factors significantly associated with COPD were age above 50 years (adjusted odds ratio [AOR] = 1.91, 95% CI [1.10, 3.30]), being smoker (AOR = 4.54, 95% CI [2.69, 7.66]), Exposed to biomass smoke (AOR = 2.05, 95% CI [1.06, 3.95]) and poor ventilated kitchen (AOR = 4.12, 95% CI [2.67, 6.34]).

Conclusion

It is evident from this study that the prevalence of COPD in Ethiopia is high. Factors such as old age, cigarette smoking, exposure to biomass smoke and poor kitchen ventilation plays a role in the development of COPD.
Literature
2.
go back to reference Anto JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J. 2001;17(5):982–94.PubMedCrossRef Anto JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J. 2001;17(5):982–94.PubMedCrossRef
3.
go back to reference Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765.PubMedCrossRef Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765.PubMedCrossRef
4.
go back to reference Mascarenhas J, Bettencourt P, Azevedo A. Clinical epidemiology of chronic obstructive pulmonary disease. Arquivos de Medicina. 2011;25(4):146–52. Mascarenhas J, Bettencourt P, Azevedo A. Clinical epidemiology of chronic obstructive pulmonary disease. Arquivos de Medicina. 2011;25(4):146–52.
5.
go back to reference GOLD. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018. https://goldcoped.org/. Accessed June 25, 2019. 2019. GOLD. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018. https://​goldcoped.​org/​. Accessed June 25, 2019. 2019.
7.
go back to reference Andreeva E, Pokhaznikova M, Lebedev A, Moiseeva I, Kutznetsova O, Degryse JM. The prevalence of chronic obstructive pulmonary disease by the global lung initiative equations in North-Western Russia. Respiration. 2016;91(1):43–55.PubMedCrossRef Andreeva E, Pokhaznikova M, Lebedev A, Moiseeva I, Kutznetsova O, Degryse JM. The prevalence of chronic obstructive pulmonary disease by the global lung initiative equations in North-Western Russia. Respiration. 2016;91(1):43–55.PubMedCrossRef
9.
go back to reference Bird Y, Moraros J, Mahmood R, Esmaeelzadeh S, Soe NM. Prevalence and associated factors of COPD among aboriginal peoples in Canada: a cross-sectional study. Int J COPD. 2017;12:1915–22.CrossRef Bird Y, Moraros J, Mahmood R, Esmaeelzadeh S, Soe NM. Prevalence and associated factors of COPD among aboriginal peoples in Canada: a cross-sectional study. Int J COPD. 2017;12:1915–22.CrossRef
10.
go back to reference Evans J, Chen Y, Camp PG, Bowie DM, McRae L. Estimating the prevalence of COPD in Canada: reported diagnosis versus measured airflow obstruction. Health Rep. 2014;25(3):3–11.PubMed Evans J, Chen Y, Camp PG, Bowie DM, McRae L. Estimating the prevalence of COPD in Canada: reported diagnosis versus measured airflow obstruction. Health Rep. 2014;25(3):3–11.PubMed
13.
go back to reference Finney LJ, Feary JR, Leonardi-Bee J, Gordon SB, Mortimer K. Chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review. Int J Tuber Lung Dis. 2013;17:583–9.CrossRef Finney LJ, Feary JR, Leonardi-Bee J, Gordon SB, Mortimer K. Chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review. Int J Tuber Lung Dis. 2013;17:583–9.CrossRef
14.
go back to reference Van Gemert F, Kirenga B, Chavannes N, Kamya M, Luzige S, Musinguzi P, et al. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study. Lancet Glob Health. 2015;3:e44–51.PubMedCrossRef Van Gemert F, Kirenga B, Chavannes N, Kamya M, Luzige S, Musinguzi P, et al. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study. Lancet Glob Health. 2015;3:e44–51.PubMedCrossRef
15.
go back to reference Bahtouee M, Maleki N, Nekouee F. The prevalence of chronic obstructive pulmonary disease in hookah smokers. Chron Respir Dis. 2018;15(2):165–72.PubMedCrossRef Bahtouee M, Maleki N, Nekouee F. The prevalence of chronic obstructive pulmonary disease in hookah smokers. Chron Respir Dis. 2018;15(2):165–72.PubMedCrossRef
16.
go back to reference Pin NT. Epidemiology of chronic obstructive pulmonary disease (COPD). Singapore Fam Physician. 2013;39(2):8–10. Pin NT. Epidemiology of chronic obstructive pulmonary disease (COPD). Singapore Fam Physician. 2013;39(2):8–10.
17.
go back to reference Abdool-Gaffar MS, Ambaram A, Ainslie GM, Bolliger CT, Feldman C, Geffen L, et al. Guideline for the management of chronic obstructive pulmonary disease: 2011 update. S Afr Med J. 2011;101:63–73.PubMed Abdool-Gaffar MS, Ambaram A, Ainslie GM, Bolliger CT, Feldman C, Geffen L, et al. Guideline for the management of chronic obstructive pulmonary disease: 2011 update. S Afr Med J. 2011;101:63–73.PubMed
18.
go back to reference Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–55.PubMedCrossRef Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–55.PubMedCrossRef
19.
go back to reference Salvi S, Barnes PJ. Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest. 2010;138:3–6.PubMedCrossRef Salvi S, Barnes PJ. Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest. 2010;138:3–6.PubMedCrossRef
20.
21.
go back to reference Van Gemert FA, Kirenga BJ, Gebremariam TH, Nyale G, de Jong C, van der Molen T. The complications of treating chronic obstructive pulmonary disease in low income countries of sub-Saharan Africa. Expert Rev Respir Med. 2018;12(3):227–37.PubMedCrossRef Van Gemert FA, Kirenga BJ, Gebremariam TH, Nyale G, de Jong C, van der Molen T. The complications of treating chronic obstructive pulmonary disease in low income countries of sub-Saharan Africa. Expert Rev Respir Med. 2018;12(3):227–37.PubMedCrossRef
22.
23.
go back to reference Martínez-Mesa J, González-Chica DA, Bastos JL, Bonamigo RR, Duquia RP. Sample size: how many participants do I need in my research? An Bras Dermatol. 2014;89(4):609–15.PubMedPubMedCentralCrossRef Martínez-Mesa J, González-Chica DA, Bastos JL, Bonamigo RR, Duquia RP. Sample size: how many participants do I need in my research? An Bras Dermatol. 2014;89(4):609–15.PubMedPubMedCentralCrossRef
24.
go back to reference Ferris BG. Epidemiology standardization project. Recommended respiratory disease questionnaires for use with adults and children in epidemiological research. Am Rev Respir Dis. 1978;118:7–57. Ferris BG. Epidemiology standardization project. Recommended respiratory disease questionnaires for use with adults and children in epidemiological research. Am Rev Respir Dis. 1978;118:7–57.
25.
go back to reference Medical Research Council’s Committee on Environmental and Occupational Health. Questionnaire on respiratory symptoms. London: Medical Research Council; 1986. Medical Research Council’s Committee on Environmental and Occupational Health. Questionnaire on respiratory symptoms. London: Medical Research Council; 1986.
26.
go back to reference WHO Expert Committee on Physical Status. Physical status: the use and interpretation of anthropometry, WHO Technical Report series no. 854, August 1. Geneva: World Health Organization; 1995. WHO Expert Committee on Physical Status. Physical status: the use and interpretation of anthropometry, WHO Technical Report series no. 854, August 1. Geneva: World Health Organization; 1995.
27.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardization of spirometry. Eur Respir J. 2005;26:319–38.PubMedCrossRef Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardization of spirometry. Eur Respir J. 2005;26:319–38.PubMedCrossRef
28.
go back to reference Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. GOLD scientific committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;163:1256–76.CrossRef Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. GOLD scientific committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;163:1256–76.CrossRef
30.
go back to reference Stockley RA, Mannino D, Barnes PJ. Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009;6(6):524–6.PubMedCrossRef Stockley RA, Mannino D, Barnes PJ. Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009;6(6):524–6.PubMedCrossRef
31.
go back to reference Badway MS, Hamed AF, Yousef FM. Prevalence of chronic obstructive pulmonary disease (COPD) in Qena governorate. Egypt J Chest Dis Tuberc. 2016;65:29–34.CrossRef Badway MS, Hamed AF, Yousef FM. Prevalence of chronic obstructive pulmonary disease (COPD) in Qena governorate. Egypt J Chest Dis Tuberc. 2016;65:29–34.CrossRef
32.
go back to reference Menezes AM, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875–81.PubMedCrossRef Menezes AM, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875–81.PubMedCrossRef
34.
go back to reference Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and nutrition examination survey. Respirology. 2011;16(4):659–65.PubMedCrossRef Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and nutrition examination survey. Respirology. 2011;16(4):659–65.PubMedCrossRef
35.
go back to reference Bárbara C, Rodrigues F, Dias H, Cardoso J, Almeida J, Matos MJ, et al. Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study. Rev Port Pneumol. 2013;19(3):96–105.PubMedCrossRef Bárbara C, Rodrigues F, Dias H, Cardoso J, Almeida J, Matos MJ, et al. Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study. Rev Port Pneumol. 2013;19(3):96–105.PubMedCrossRef
36.
go back to reference Vanfleteren LE, Franssen FM, Wesseling G, Wouters EF. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands. Respir Med. 2012;106(6):871–4.PubMedCrossRef Vanfleteren LE, Franssen FM, Wesseling G, Wouters EF. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands. Respir Med. 2012;106(6):871–4.PubMedCrossRef
37.
go back to reference Minas M, Hatzoglou C, Karetsi E, Papaioannou AI, Tanou K, Tsaroucha R, et al. COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry program. Prim Care Respir J. 2010;19(4):363–70.PubMedPubMedCentralCrossRef Minas M, Hatzoglou C, Karetsi E, Papaioannou AI, Tanou K, Tsaroucha R, et al. COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry program. Prim Care Respir J. 2010;19(4):363–70.PubMedPubMedCentralCrossRef
38.
go back to reference Chuchalin AG, Khaltaev N, Antonov NS, Galkin DV, Manakov LG, Antonini P, et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J Chron Obstruct Pulmon Dis. 2014;9:963–74.PubMedPubMedCentralCrossRef Chuchalin AG, Khaltaev N, Antonov NS, Galkin DV, Manakov LG, Antonini P, et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J Chron Obstruct Pulmon Dis. 2014;9:963–74.PubMedPubMedCentralCrossRef
40.
go back to reference Alam DS, Chowdhury MA, Siddiquee AT, Ahmed S, Clemens JD. Prevalence and determinants of chronic obstructive pulmonary disease (COPD) in Bangladesh. COPD: J Chron Obstruct Pulmon Dis. 2015;12(6):658–67. Alam DS, Chowdhury MA, Siddiquee AT, Ahmed S, Clemens JD. Prevalence and determinants of chronic obstructive pulmonary disease (COPD) in Bangladesh. COPD: J Chron Obstruct Pulmon Dis. 2015;12(6):658–67.
42.
go back to reference Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733–43.PubMedCrossRef Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733–43.PubMedCrossRef
43.
go back to reference Ramírez-Venegas A, Velázquez-Uncal M, Pérez-Hernández R, Guzmán-Bouilloud NE, Falfán-Valencia R, Mayar-Maya ME, et al. Prevalence of COPD and respiratory symptoms associated with biomass smoke exposure in a suburban area. Int J COPD. 2018;13:1727–34.CrossRef Ramírez-Venegas A, Velázquez-Uncal M, Pérez-Hernández R, Guzmán-Bouilloud NE, Falfán-Valencia R, Mayar-Maya ME, et al. Prevalence of COPD and respiratory symptoms associated with biomass smoke exposure in a suburban area. Int J COPD. 2018;13:1727–34.CrossRef
46.
go back to reference Gordon SB, Bruce NG, Grigg J, Hibberd PL, Kurmi OP, Lam KB, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014;2:823–60.PubMedPubMedCentralCrossRef Gordon SB, Bruce NG, Grigg J, Hibberd PL, Kurmi OP, Lam KB, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014;2:823–60.PubMedPubMedCentralCrossRef
47.
go back to reference Kiraz K, Kart L, Emir R, Oymak S, Gulmez I, Unalacak M, et al. Chronic pulmonary disease in rural women exposed to boimass fumes. Clin Invest Med. 2003;26:243–8.PubMed Kiraz K, Kart L, Emir R, Oymak S, Gulmez I, Unalacak M, et al. Chronic pulmonary disease in rural women exposed to boimass fumes. Clin Invest Med. 2003;26:243–8.PubMed
48.
go back to reference Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ. 2000;78(9):1078–92.PubMedPubMedCentral Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ. 2000;78(9):1078–92.PubMedPubMedCentral
49.
go back to reference Daldoul H, Denguezli M, Jithoo A, Gnatiuc L, Buist S, Burney P, et al. Prevalence of COPD and tobacco smoking in Tunisia − results from the BOLD study. Int J Environ Res Public Health. 2013;10:7257–71.PubMedPubMedCentralCrossRef Daldoul H, Denguezli M, Jithoo A, Gnatiuc L, Buist S, Burney P, et al. Prevalence of COPD and tobacco smoking in Tunisia − results from the BOLD study. Int J Environ Res Public Health. 2013;10:7257–71.PubMedPubMedCentralCrossRef
50.
go back to reference Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63(12):1046–51.PubMedCrossRef Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63(12):1046–51.PubMedCrossRef
Metadata
Title
Prevalence of chronic obstructive pulmonary disease (COPD) and its associated factors among adults in Abeshge District, Ethiopia: a cross sectional study
Authors
Gashaw Garedew Woldeamanuel
Alemu Basazin Mingude
Teshome Gensa Geta
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2019
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-019-0946-z

Other articles of this Issue 1/2019

BMC Pulmonary Medicine 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.